AB 2643 edits Insurance Code section 742 to tidy language that defines which entities fall under Department of Insurance (DOI) jurisdiction for coverage tied to preferred provider organizations (PPOs). The amended paragraph identifies persons or entities that provide certain categories of health coverage and that "enter into an arrangement or contract with, or underwrite, a preferred provider organization or arrangement" as subject to DOI oversight.
The bill also restates an exclusion: organizations regulated under Chapter 2.2 (commencing with Section 1340) of the Health and Safety Code are not subject to §742. Practically, this codifies the boundary between DOI authority and entities governed by the Knox‑Keene framework, reducing textual ambiguity but not creating new regulatory duties.
At a Glance
What It Does
AB 2643 revises the wording of Insurance Code §742(a) to specify that providers of medical and related coverage who enter into or underwrite preferred‑provider arrangements are subject to the Department of Insurance. It also preserves a carved‑out exclusion for entities regulated under Health & Safety Code Chapter 2.2.
Who It Affects
Insurers, underwriters, and other entities that offer or underwrite coverage tied to preferred‑provider organizations; health care service plans regulated under the Knox‑Keene Act; and compliance/legal teams at DOI and the Department of Managed Health Care (DMHC).
Why It Matters
The bill sharpens the statutory language that allocates oversight between DOI and the Knox‑Keene regime, which matters for contract drafting, regulatory filings, and enforcement jurisdiction. For compliance officers, it reduces a source of uncertainty about which state agency will review PPO arrangements.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The text of AB 2643 makes narrowly targeted edits to Insurance Code §742. It reorganizes and refines the sentence that attaches DOI jurisdiction to entities that provide specific categories of health‑related coverage and that either enter into arrangements with, or underwrite, preferred provider organizations or arrangements.
Those covered services listed in the statute include familiar categories (medical, surgical, mental health, dental, etc.), and the change is primarily language tightening rather than a new policy overlay.
Alongside the rewording, the bill repeats an exclusion: any person or entity already regulated under Health and Safety Code Chapter 2.2 is not subject to §742. Chapter 2.2 is the statutory home for the Knox‑Keene Health Care Service Plan Act, which establishes the DMHC’s supervisory authority over health care service plans.
By reaffirming that carve‑out in §742(b), the amendment aims to cement the existing division of labor between DOI and the DMHC for certain kinds of coverage and network arrangements.Because the changes are framed as technical and nonsubstantive, AB 2643 does not impose new compliance obligations, fees, or penalties; it does, however, require actors to be precise about which statutory regime governs their product. In practice, carriers and counsel should map existing PPO contracts and underwriting practices against both Insurance Code §742 and the Knox‑Keene statutes to confirm where DOI or DMHC authority applies.
Regulators may rely on the clarified text when asserting jurisdiction or declining to act, so the amendment matters most as an interpretive tool in enforcement and contract disputes.
The Five Things You Need to Know
The bill revises Ins. Code §742(a) to state explicitly that entities providing listed health services who enter into or underwrite preferred‑provider arrangements are under DOI jurisdiction.
Section 742 now ties its reach to preferred‑provider arrangements that fall within the scope of Section 10133 (the statutory cross‑reference remains part of the clause defining covered arrangements).
AB 2643 keeps an explicit exemption in §742(b): persons or entities regulated under Health & Safety Code Chapter 2.2 (Knox‑Keene) are excluded from §742’s coverage.
The Legislature designates the edits as technical and nonsubstantive, so the bill does not add new regulatory duties or penalties on its face.
Practical consequence: insurers, plan sponsors, and counsel should confirm whether a given product is governed by DOI or by Knox‑Keene and update internal compliance categorizations and contractual language accordingly.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Identifies which coverage‑providers fall under DOI for PPO arrangements
This paragraph rephrases the list of services and the triggering conduct that attaches DOI jurisdiction: providing coverage for certain services and entering into or underwriting a preferred‑provider arrangement. The practical effect is clarifying the statute’s subject — who is captured — without changing the substantive scope of the listed services. For compliance teams, the immediate task is to confirm whether current PPO contracts or underwriting relationships meet the statutory trigger language as written.
Restates the exemption for entities governed by Chapter 2.2 (Knox‑Keene)
Subsection (b) reaffirms that entities already regulated under Health & Safety Code Chapter 2.2 are outside §742’s reach. That exclusion preserves the DMHC’s domain over health care service plans and prevents §742 from being read as an expansion of DOI authority into areas governed by Knox‑Keene. Where jurisdictional disputes arise, regulators and courts will look to this language when determining the appropriate supervisory agency.
Grammar and phrasing edits intended to reduce ambiguity
The bill’s stated purpose is technical cleanup: small wording adjustments (for example, reordering clauses and changing determiners) intended to reduce interpretive uncertainty. While these changes do not create new regulatory obligations, they may influence administrative interpretations and the drafting of enforcement notices or guidance that reference §742.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Department of Insurance — Gains clearer statutory language to rely on when asserting jurisdiction over insurers that enter into or underwrite PPO arrangements, reducing ambiguity in enforcement decisions.
- Health care service plans regulated under Knox‑Keene (DMHC‑regulated plans) — Receive an explicit restatement of their exemption from §742, which reduces the risk of overlapping oversight by DOI for activities already regulated by DMHC.
- Insurers and underwriters — Obtain more predictable statutory language, which lowers the compliance risk associated with unclear jurisdictional boundaries and helps inform contract drafting and risk allocation.
- Compliance and legal teams — Benefit from a clarified statutory hook for audits and internal policies, enabling targeted reviews of whether products fall under DOI or Knox‑Keene supervision.
Who Bears the Cost
- Insurers and plan sponsors — Must spend time and legal resources to revalidate whether existing products and contracts fall under DOI jurisdiction or are exempt, even though the bill is technical.
- Legal and compliance departments at small carriers — May face disproportionate administrative burden updating internal playbooks and contract templates to reflect clarified language.
- Department of Managed Health Care (DMHC) — May need to respond to inquiries or coordinate jurisdictional questions with DOI when carriers argue exemption under Chapter 2.2.
- Regulated providers and networks — Could encounter temporary uncertainty when counterparties reclassify arrangements to align with the clarified statutory language, requiring renegotiation or additional documentation.
Key Issues
The Core Tension
The central dilemma is balancing regulatory clarity against the risk of creating new gaps: giving DOI clearer authority over certain PPO arrangements reduces duplication and uncertainty, but tightening the statutory boundary and reaffirming the Knox‑Keene exemption could leave room for entities to restructure products to fall outside one regulator’s oversight, potentially producing uneven consumer protections.
Labeling the edits as "technical, nonsubstantive" narrows the bill’s effect on its face, but that characterization does not eliminate interpretive consequences. Small shifts in phrasing can change the emphasis courts or agencies place on particular statutory elements — for example, the difference between "entering into an arrangement with" and other forms of contractual relationships could be litigated when a party argues it falls outside DOI reach.
The cross‑reference to Section 10133 matters because it anchors §742’s coverage to arrangements that meet whatever standard that section sets; if Section 10133 is itself ambiguous or broadly construed, §742’s practical scope will depend on how that other provision is interpreted. The bill does not address or harmonize definitions (such as "underwrite" or what it means to "enter into an arrangement"), so interpretive disputes may simply shift rather than disappear.
Finally, by clarifying the Knox‑Keene carve‑out, the bill reduces overlap but leaves open possibilities for regulatory arbitrage: entities seeking to avoid one regulator might redesign products to fit under the other regime, raising questions about consumer protection parity across frameworks.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.